Medical History And Record Keeping Made Easier For You
We translate generic result into actionable reports and clinical decision recommendation so that you can be given better care, faster.
We translate generic result into actionable reports and clinical decision recommendation so that you can be given better care, faster.
8%
of all hospital admissions are caused by ADRs
30%
of adverse drug reactions have significant genetic associations.
50%
of ADRs are caused by outpatient medications.
Our tests comply with local and international regulatory standards for medical devices and we protect our web and mobile applications with robust measures
Our reports are generated with the most recent and relevant pharmacogenomic findings. Get actionable recommendations to determine the best follow up action for your patients with our pre-loaded clinical decision support system.
Strengthen the trust between you and your patients by connecting with them through the app. The Nalagenetics app enables doctors and patients to share reports securely, report adverse events and chat anytime with a dedicated patient care manager.
Nala Outpatient is a pharmacogenomics test designed to analyze the five genes and 30+ most commonly prescribed drugs in an outpatient setting.
Though 81% of doctors believe that pharmacogenomic testing would be useful, only 46.4% feel competent enough to implement the science into their practice. We seek to bridge this gap by offering a full suite of simple, easy-to-use pharmacogenetic tools.
The test will show your patient’s important pharmacogene phenotype and its implication on each of the drug response. This implication will be augmented with trusted recommendations taken from well-known consortia such as CPIC (Clinical Pharmacogenomics Implementation Consortium) and DPWG as well as from regulatory bodies such as The US’s FDA and Europe’s EMA. To see what our report looks like, please click here.
Swabbing your patient’s buccal (inner cheek) area for sample using our cotton swab will need at most two minutes to complete. This procedure is done in your clinic. This sample will then be sent to our lab and the report will be available for the doctor’s review in around one to five days.
NalaTM PGx Suite in Singapore is currently a Research-Use Only kit that has been evaluated for use as a Lab-Developed Test in a clinical laboratory licensed under the Private Hospitals and Medical Clinics Act of Singapore.
The recommendations stated in the report are always backed by scientific evidence. Should the report’s caveat mention that the recommendation is only for a certain condition, it means that we do not have sufficient information to provide a genetic-based recommendation for other conditions. We advise that you exercise your clinical judgment in such cases.